RFG Advisory LLC Has $604,000 Stock Holdings in The Chemours Company $CC

RFG Advisory LLC trimmed its holdings in shares of The Chemours Company (NYSE:CCFree Report) by 51.3% during the first quarter, HoldingsChannel reports. The fund owned 27,405 shares of the specialty chemicals company’s stock after selling 28,915 shares during the quarter. RFG Advisory LLC’s holdings in Chemours were worth $604,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CC. Cooper Creek Partners Management LLC acquired a new position in shares of Chemours during the third quarter worth $63,103,000. Scopia Capital Management LP increased its holdings in Chemours by 71.7% in the second quarter. Scopia Capital Management LP now owns 3,355,261 shares of the specialty chemicals company’s stock valued at $38,418,000 after purchasing an additional 1,401,539 shares during the period. State Street Corp increased its holdings in Chemours by 22.7% in the second quarter. State Street Corp now owns 6,114,328 shares of the specialty chemicals company’s stock valued at $70,009,000 after purchasing an additional 1,131,682 shares during the period. Wolf Hill Capital Management LP bought a new position in Chemours during the 3rd quarter worth $17,025,000. Finally, Sona Asset Management US LLC raised its position in Chemours by 176.9% during the 4th quarter. Sona Asset Management US LLC now owns 1,651,275 shares of the specialty chemicals company’s stock worth $19,469,000 after purchasing an additional 1,055,000 shares during the last quarter. 76.26% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on CC shares. Royal Bank Of Canada upped their price target on Chemours from $26.00 to $29.00 and gave the company an “outperform” rating in a research report on Monday, May 11th. UBS Group raised their price objective on Chemours from $29.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, May 8th. Truist Financial lifted their price objective on Chemours from $27.00 to $30.00 and gave the stock a “buy” rating in a research note on Tuesday, April 28th. Weiss Ratings reiterated a “sell (d)” rating on shares of Chemours in a report on Monday, April 20th. Finally, Mizuho set a $30.00 target price on shares of Chemours in a research report on Wednesday, May 6th. Six equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Chemours currently has a consensus rating of “Hold” and a consensus target price of $24.60.

Read Our Latest Analysis on Chemours

Chemours Stock Performance

Shares of Chemours stock opened at $20.04 on Tuesday. The company has a current ratio of 1.82, a quick ratio of 0.87 and a debt-to-equity ratio of 18.98. The business has a 50-day moving average price of $22.81 and a two-hundred day moving average price of $19.09. The Chemours Company has a 1-year low of $10.44 and a 1-year high of $28.67. The company has a market cap of $3.01 billion, a P/E ratio of -7.59 and a beta of 1.40.

Chemours (NYSE:CCGet Free Report) last posted its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $0.05 earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.10. Chemours had a positive return on equity of 52.49% and a negative net margin of 6.82%.The firm had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.40 billion. During the same period last year, the company posted $0.13 EPS. The business’s quarterly revenue was up 1.0% on a year-over-year basis. As a group, analysts anticipate that The Chemours Company will post 1.07 EPS for the current year.

Chemours Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Sunday, May 17th were issued a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date was Friday, May 15th. Chemours’s payout ratio is presently -13.26%.

Chemours Company Profile

(Free Report)

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.

Recommended Stories

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CCFree Report).

Institutional Ownership by Quarter for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.